Nestlé Health Science, a globally recognized leader in the field of nutritional science, has agreed to acquire the business of IM HealthScience with its brands of IBgard, FDgard, Fiber Choice, and REMfresh.

“The IMH products offer proven and trusted solutions for dietary management of specific digestive problems as well as a separate solution for regulating sleep,” said Greg Behar, CEO of Nestlé Health Science. “IMH’s dedication to developing products to address overall health and wellness by bringing cutting-edge life science and world class research fits perfectly with our mission of empowering healthier lives through nutrition.”

IMH is the innovator of IBgard and FDgard for the dietary management of IBS (Irritable Bowel Syndrome) and FD (Functional Dyspepsia), respectively. In 2017, IMH added Fiber Choice, a line of prebiotic fibers, to its product line via an acquisition. REMfresh is a continuous release-and-absorption melatonin (CRA-melatonin) supplement for sleep.

“Science, patents, and meaningful differentiation has enabled our company to grow at several times faster than the market” said Fred Hassan, chairman and founder of IM HealthScience. “IBgard, FDgard, and Fiber Choice have become the number one recommended by gastroenterologists in their own segments and REMfresh is the number one sleep aid recommended by sleep specialists. The high repeat purchase rates of our four brands attest to the high patient satisfaction. We are glad that our brands have helped millions and now, under Nestlé Health Science’s able hand, millions more will benefit around the world. We are confident that under the dynamic leadership of Greg Behar, our products will keep thriving and growing.”